Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationGuidance outlines the process for gaining approval to conduct clinical investigations in the UK.
EMA outlines priorities and objectives for inspection activities over the next three years.
Industry Highlights edition 1 and Clinical Trials Highlights edition 31.
UK guidance sets out requirements for assessing environmental risks of medicinal products.
Updated UK guidance outlines expectations for complying with ICH E6 Good Clinical Practice in clinical trials.
New UK guidance highlights a proportionate approach to quality and risk management in clinical trials.
Watch the MHRA webinar on Implementing the new UK Clinical Trials regulations, which took place on Thursday, 12 March 2026.
The MHRA highlights the importance of international collaboration to drive innovation in healthcare regulation.
A new approach to the Innovative Licensing and Access Pathway aims to provide earlier guidance and greater predictability for developers.
An update outlining MHRA’s progress and future direction for improving clinical trial pathways in the UK.